Molecular Imaging: Page 117

CT for brain metastasis unnecessary after PET/CT

By Eric Barnes

A CT scan is often ordered to find brain metastases in lung cancer patients. But if a whole-body PET/CT scan is already available from the original workup, there's no need for a dedicated CT scan, according to researchers from Belgium, who found that the CT portion of the PET/CT scan is enough for the initial diagnosis.

April 1, 2009

New MRI techniques could mean faster scans

By Reuters Health

LONDON (Reuters), Mar 27 - Two new techniques using different approaches to see molecular changes inside people's bodies could lead to faster, more detailed imaging scans that better detect health problems, researchers said on Thursday.

March 26, 2009

Siemens nets London PET/CT, CT installs

By AuntMinnieEurope.com staff writers

Siemens Healthcare has completed three London installs of its PET/CT and CT systems.

March 10, 2009

IBA inks pact with Eczacıbaşı-Monrol

By AuntMinnieEurope.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) will use Eczacıbaşı-Monrol Nuclear Products of Gebze, Turkey, to expand into the Balkans, Middle East, North Africa, and central and eastern Europe.

February 8, 2009

Bayer partners with Hamamatsu

By AuntMinnieEurope.com staff writers

Bayer Schering Pharma and Hamamatsu Photonics have signed a licensing agreement to share their products and expertise in molecular imaging for cancer.

January 11, 2009

MRI beats PET for myocardial evaluation in patients with impaired LV function

By Eric Barnes

While MRI is known to detect more myocardial scarring than PET in patients with occlusive coronary artery disease, a new study suggests that contrast-enhanced MRI can make a critical difference in treatment planning for revascularization candidates with severely impaired left ventricular (LV) function.

January 8, 2009

PET-based F-18 FLT equivocal for leukemia imaging

By Wayne Forrest

Researchers in Germany and the U.S. hoped that switching radiopharmaceuticals from FDG might improve PET's performance for imaging leukemia. While they found some benefits to using the new tracer, they also discovered some shortcomings.

January 6, 2009

Medrad sponsors Swiss PET project

By AuntMinnieEurope.com staff writers

Contrast injector technology firm Medrad signed a research agreement with the University of Zurich to study dynamic PET imaging with the Medrad Intego PET infusion system.

January 5, 2009

SPECT/CT outdoes planar imaging with lymph nodes

By Wayne Forrest

A newly released study in this month's issue of the Journal of Nuclear Medicine has found that SPECT/CT is better than planar imaging in accurately determining lymph node involvement at radioablation performed for thyroid cancer.

January 4, 2009

FDG-PET/CT recommended for staging Hodgkin's disease

By Wayne Forrest

A British study confirms the high sensitivity and specificity of PET/CT in identifying focal bony disease in patients with Hodgkin's disease, according to research presented at the recent 2008 RSNA meeting. The results further suggest that the imaging modality can play an important role in initial staging of the disease.

December 18, 2008

IBA opens Dallas PET facility

By AuntMinnieEurope.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) has opened a new PET radiopharmaceutical production facility in Dallas.

December 16, 2008

IBA responds to FDA warning letter

By AuntMinnieEurope.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) has responded to a warning letter from the U.S. Food and Drug Administration related to manufacturing practices for PET radiotracers at a facility in Virginia.

December 10, 2008

Previous Page

Page 117 of 122

Next Page